Literature DB >> 9734469

Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments.

R J Solaro1, H M Rarick.   

Abstract

We present a current perception of the regulation of activation of cardiac myofilaments with emphasis on troponin (Tn) and tropomyosin (Tm). Activation involves both a Ca2+-regulated molecular switch and a potentiated state, dependent on feedback effects of force-generating crossbridges. Recent developments in the elucidation of the structure and arrangement of the myofilament proteins offer insights into the molecular interactions that constitute the switching and potentiating mechanisms. Transgenic mice overexpressing myofilament proteins, in vitro studies of mutant myofilament proteins, multidimensional multinuclear nuclear magnetic resonance, and fluorescence resonance energy transfer offer important approaches to understanding the molecular signaling processes. These studies reveal special features of the cardiac myofilament proteins that appear specialized for the unique functions of the heart. An important aspect of these special features is their role in mechanical, chemical, and neurohumoral coupling processes that tune myofilament activation to hemodynamics and beating frequency. Understanding these processes has become essential to understanding cardiac pathologies such as heart failure, ischemia and reperfusion injury, stunning, and familial hypertrophic cardiac myopathies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9734469     DOI: 10.1161/01.res.83.5.471

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  82 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Different myofilament nearest-neighbor interactions have distinctive effects on contractile behavior.

Authors:  M V Razumova; A E Bukatina; K B Campbell
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

3.  Alternative splicing, muscle calcium sensitivity, and the modulation of dragonfly flight performance.

Authors:  J H Marden; G H Fitzhugh; M R Wolf; K D Arnold; B Rowan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  3-Dimensional configuration of perimysial collagen fibres in rat cardiac muscle at resting and extended sarcomere lengths.

Authors:  P J Hanley; A A Young; I J LeGrice; S G Edgar; D S Loiselle
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

Review 5.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

6.  Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart.

Authors:  R C Fentzke; S H Buck; J R Patel; H Lin; B M Wolska; M O Stojanovic; A F Martin; R J Solaro; R L Moss; J M Leiden
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

7.  Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I.

Authors:  Yong Zhao; Xian-Min Meng; Ying-Jie Wei; Xiu-Wen Zhao; Dong-Qing Liu; Hui-Qing Cao; Choong-Chin Liew; Jin-Feng Ding
Journal:  J Mol Med (Berl)       Date:  2003-04-30       Impact factor: 4.599

8.  Sarcomere-length dependence of lattice volume and radial mass transfer of myosin cross-bridges in rat papillary muscle.

Authors:  Naoto Yagi; Hiroshi Okuyama; Hiroko Toyota; Junichi Araki; Juichiro Shimizu; Gentaro Iribe; Kazufumi Nakamura; Satoshi Mohri; Katsuhiko Tsujioka; Hiroyuki Suga; Fumihiko Kajiya
Journal:  Pflugers Arch       Date:  2004-02-06       Impact factor: 3.657

9.  Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing.

Authors:  John P Konhilas; Thomas C Irving; Beata M Wolska; Eias E Jweied; Anne F Martin; R John Solaro; Pieter P de Tombe
Journal:  J Physiol       Date:  2003-01-24       Impact factor: 5.182

10.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.